As of 2025-10-29, the Relative Valuation of Deciphera Pharmaceuticals Inc (DCPH) is (34.13) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.59 USD, the upside of Deciphera Pharmaceuticals Inc based on Relative Valuation is -233.4%.
The range of the Relative Valuation is (27.48) - (37.96) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.5x - 17.2x | 15.6x |
| Forward P/E multiples | 12.3x - 18.7x | 15.4x |
| Fair Price | (27.48) - (37.96) | (34.13) |
| Upside | -207.4% - -248.3% | -233.4% |
| Date | P/E |